Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2006 May 09;10319:7270-5. doi: 10.1073/pnas.0602365103.
Show Gene links
Show Anatomy links
Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT.
Paroder V
,
Spencer SR
,
Paroder M
,
Arango D
,
Schwartz S
,
Mariadason JM
,
Augenlicht LH
,
Eskandari S
,
Carrasco N
.
???displayArticle.abstract???
We report an extensive characterization of the Na(+)/monocarboxylate transporter (SMCT), a plasma membrane protein that mediates active transport of monocarboxylates such as propionate and nicotinate, and we show that SMCT may play a role in colorectal cancer diagnosis. SMCT, the product of the SLC5A8 gene, is 70% similar to the Na(+)/I(-) symporter, the protein that mediates active I(-) uptake in the basolateral surface of thyrocytes and other cells. SMCT was reported in the apical surface of thyrocytes and formerly proposed also to transport I(-) and was called the apical I(-) transporter. However, it is now clear that SMCT does not transport I(-). Here we demonstrate a high-affinity Na(+)-dependent monocarboxylate transport system in thyroid cells, which is likely to be SMCT. We show that, whereas thyroidal Na(+)/I(-) symporter expression is thyroid-stimulating hormone (TSH)-dependent and basolateral, SMCT expression is TSH-independent and apical not only in the thyroid but also in kidney and colon epithelial cells and in polarized Madin-Darby canine kidney cells. We determine the kinetic parameters of SMCT activity and show its inhibition by ibuprofen (K(i) = 73 +/- 9 microM) in Xenopus laevis oocytes. SMCT was proposed to be a tumor suppressor in colon cancer. Significantly, we show that higher expression of SMCT in colon samples from 113 colorectal cancer patients correlates with longer disease-free survival, suggesting that SMCT expression may be a favorable indicator of colorectal cancer prognosis.
Alhopuro,
SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
2005, Pubmed
Alhopuro,
SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
2005,
Pubmed
Arango,
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
2005,
Pubmed
Benhattar,
Prognostic significance of K-ras mutations in colorectal carcinoma.
1993,
Pubmed
Carrasco,
Preparation of monoclonal antibodies and site-directed polyclonal antibodies against the lac permease of Escherichia coli.
1986,
Pubmed
Coady,
The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter.
2004,
Pubmed
,
Xenbase
Cohen,
Par-1 promotes a hepatic mode of apical protein trafficking in MDCK cells.
2004,
Pubmed
Dai,
Cloning and characterization of the thyroid iodide transporter.
1996,
Pubmed
,
Xenbase
De La Vieja,
Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
2000,
Pubmed
De La Vieja,
The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
2004,
Pubmed
Dohán,
Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases.
2001,
Pubmed
Dohán,
Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.
2002,
Pubmed
Dohán,
The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
2003,
Pubmed
Eskandari,
Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity.
1997,
Pubmed
,
Xenbase
Fanelli,
MCT1 and its accessory protein CD147 are differentially regulated by TSH in rat thyroid cells.
2003,
Pubmed
Gopal,
Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family.
2005,
Pubmed
,
Xenbase
Gopal,
Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate.
2004,
Pubmed
,
Xenbase
Halestrap,
The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.
2004,
Pubmed
Hong,
Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
2005,
Pubmed
Jen,
Allelic loss of chromosome 18q and prognosis in colorectal cancer.
1994,
Pubmed
Lacroix,
Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.
2004,
Pubmed
Levy,
Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody.
1997,
Pubmed
,
Xenbase
Levy,
Identification of a structural requirement for thyroid Na+/I- symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism.
1998,
Pubmed
Levy,
N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model.
1998,
Pubmed
Li,
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
2003,
Pubmed
Miyauchi,
Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids.
2004,
Pubmed
,
Xenbase
Riedel,
Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin.
2001,
Pubmed
Rodriguez,
Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.
2002,
Pubmed
Rodriguez-Boulan,
Organization of vesicular trafficking in epithelia.
2005,
Pubmed
Roediger,
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.
1980,
Pubmed
Tazebay,
The mammary gland iodide transporter is expressed during lactation and in breast cancer.
2000,
Pubmed
Watanabe,
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
2001,
Pubmed
Whitlow,
The anticonvulsant valproate increases the turnover rate of gamma-aminobutyric acid transporters.
2003,
Pubmed
,
Xenbase
Zuckier,
Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
2004,
Pubmed